PMID- 30170548 OWN - NLM STAT- MEDLINE DCOM- 20190415 LR - 20230928 IS - 1471-2350 (Electronic) IS - 1471-2350 (Linking) VI - 19 IP - 1 DP - 2018 Aug 31 TI - Common FTO rs9939609 variant and risk of type 2 diabetes in Palestine. PG - 156 LID - 10.1186/s12881-018-0668-8 [doi] LID - 156 AB - BACKGROUND: Genetic and environmental factors play a crucial role in the development of type 2 diabetes mellitus (T2DM) and obesity. This study aimed to investigate the association of the fat-mass and obesity-associated gene (FTO) rs9939609 variant with T2DM and body mass index (BMI) among Palestinian population. METHODS: A total of 399 subjects were recruited, of whom 281 were type 2 diabetic patients and 118 normoglycemic subjects. All of them were unrelated, aged > 40 years and recruited within the period 2016-2017. The A allele of FTO rs9939609 was identified by PCR-RFLP. RESULTS: Significant association of the minor allele A of FTO rs9939609 and T2DM risk was observed with an allelic odd ratio of 1.92 (95% CI [1.09-3.29], p = 0.02) adjusted for age and gender, this association partly attenuated when adjusted for BMI with OR of 1.84, (95%CI [1.04-3.05], p = 0.03). Stratified data by glycemic status across FTO genotypes showed that A allele was marginally associated with increased BMI among diabetic group (p = 0.057) but not in control group (p = 0.7). Moreover, no significant association was observed between FTO genotypes and covariates of age, gender, T2DM complications or any tested metabolic trait in both diabetic and nondiabetic individuals (p > 0.05). CONCLUSIONS: The variant rs9939609 of the FTO gene was associated with T2DM in Palestine. This is the first study conducted on this gene in the Palestinian population and provides valuable information for comparison with other ethnic groups. Further analysis with larger sample size is required to elucidate the role of this variant on the predisposition to increased BMI in Palestinians. FAU - Sabarneh, Anas AU - Sabarneh A AD - Biochemistry and Molecular Biology Department, Faculty of Medicine, Al-Quds University, Abu Dis-East Jerusalem, Palestine. FAU - Ereqat, Suheir AU - Ereqat S AUID- ORCID: 0000-0003-3706-5732 AD - Biochemistry and Molecular Biology Department, Faculty of Medicine, Al-Quds University, Abu Dis-East Jerusalem, Palestine. sereqat@staff.alquds.edu. AD - Al-Quds Nutrition and Health Research Institute - Faculty of Medicine, Al-Quds University-Palestine, Abu Dis-Jerusalem, Palestine. sereqat@staff.alquds.edu. FAU - Cauchi, Stephane AU - Cauchi S AD - CNRS, UMR8204, Lille, France. AD - INSERM, U1019, Lille, France. AD - Universite de Lille, Lille, France. AD - Institut Pasteur de Lille, Centre d'Infection et d'Immunite de Lille, Lille, France. FAU - AbuShamma, Omar AU - AbuShamma O AD - Biochemistry and Molecular Biology Department, Faculty of Medicine, Al-Quds University, Abu Dis-East Jerusalem, Palestine. FAU - Abdelhafez, Mohammad AU - Abdelhafez M AD - Biochemistry and Molecular Biology Department, Faculty of Medicine, Al-Quds University, Abu Dis-East Jerusalem, Palestine. FAU - Ibrahim, Murad AU - Ibrahim M AD - Microbiology and immunology Department-Faculty of Medicine, Al-Quds University-Palestine, Abu Dis-East Jerusalem, Palestine. FAU - Nasereddin, Abdelmajeed AU - Nasereddin A AD - Al-Quds Nutrition and Health Research Institute - Faculty of Medicine, Al-Quds University-Palestine, Abu Dis-Jerusalem, Palestine. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180831 PL - England TA - BMC Med Genet JT - BMC medical genetics JID - 100968552 RN - EC 1.14.11.33 (Alpha-Ketoglutarate-Dependent Dioxygenase FTO) RN - EC 1.14.11.33 (FTO protein, human) SB - IM MH - Alleles MH - Alpha-Ketoglutarate-Dependent Dioxygenase FTO/*genetics MH - Arabs/*genetics MH - Body Mass Index MH - Case-Control Studies MH - Diabetes Mellitus, Type 2/*genetics MH - Female MH - Genetic Predisposition to Disease/*genetics MH - Genetic Variation/*genetics MH - Genotype MH - Humans MH - Male MH - Middle Aged MH - Obesity/genetics MH - Risk PMC - PMC6119238 OTO - NOTNLM OT - BMI OT - FTO OT - Palestine OT - T2DM OT - rs9939609 variant COIS- ETHICS APPROVAL AND CONSENT TO PARTICIPATE: All the study procedures were approved by the Ethics Committee of Al-Quds University (Rf no. 2/SRC/4). Informed consent was obtained from all individual participants included in the study. CONSENT FOR PUBLICATION: Written consent was obtained from all participants to publish their data. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER'S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EDAT- 2018/09/02 06:00 MHDA- 2019/04/16 06:00 PMCR- 2018/08/31 CRDT- 2018/09/02 06:00 PHST- 2018/05/01 00:00 [received] PHST- 2018/08/17 00:00 [accepted] PHST- 2018/09/02 06:00 [entrez] PHST- 2018/09/02 06:00 [pubmed] PHST- 2019/04/16 06:00 [medline] PHST- 2018/08/31 00:00 [pmc-release] AID - 10.1186/s12881-018-0668-8 [pii] AID - 668 [pii] AID - 10.1186/s12881-018-0668-8 [doi] PST - epublish SO - BMC Med Genet. 2018 Aug 31;19(1):156. doi: 10.1186/s12881-018-0668-8.